{
  "id": "6053ba5b94d57fd879000017",
  "type": "factoid",
  "question": "Which was  the first oral drug for the treatment of multiple sclerosis by the US Food and Drug Administration (FDA)?",
  "ideal_answer": "FTY720 (Fingolimod) was approved as the first oral drug for the treatment of multiple sclerosis by the US Food and Drug Administration (FDA) in 2010.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/31785606"
  ],
  "snippets": [
    {
      "text": "FTY720 (Fingolimod) is a known sphingosine-1-phosphate (S1P) receptor agonist that exerts strong anti-inflammatory effects and was approved as the first oral drug for the treatment of multiple sclerosis by the US Food and Drug Administration (FDA) in 2010. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31785606",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "FTY720, Fingolimod"
}